A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)
Clinical trial NCT03929679 · COMPLETED
Trial details
- NCT number
- NCT03929679
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-05-28
- Primary completion
- 2020-11-24
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.